GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
PDB ID | UniProt ID | Title ▼ | Descriptor |
---|---|---|---|
A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES
|
INFLUENZA B/LEE/40 NEURAMINIDASE (SIALIDASE) (E.C.3.2.1.18) COMPLEXED WITH EPANA INHIBITOR (4-ACETAMIDO-2,4-DIDEOXY-D-GLYCERO-ALPHA-D-GALACTO-1-OCTOPYRANOSYL) PHOSPHONIC ACID
|
||
A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES
|
INFLUENZA A SUBTYPE N2 NEURAMINIDASE (SIALIDASE) (E.C.3.2.1.18) COMPLEXED WITH APANA INHIBITOR (4-ACETAMIDO-2,4-DIDEOXY-D-GLYCERO-BETA-D-GALACTO-1-OCTOPYRANOSYL) PHOSPHONIC ACID
|
||
A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES
|
INFLUENZA A SUBTYPE N2 NEURAMINIDASE (SIALIDASE) (E.C.3.2.1.18) COMPLEXED WITH EPANA INHIBITOR (4-ACETAMIDO-2,4-DIDEOXY-D-GLYCERO-ALPHA-D-GALACTO-1-OCTOPYRANOSYL) PHOSPHONIC ACID
|
||
A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES
|
INFLUENZA A SUBTYPE N9 NEURAMINIDASE (SIALIDASE) (E.C.3.2.1.18) COMPLEXED WITH EPANA INHIBITOR (4-ACETAMIDO-2,4-DIDEOXY-D-GLYCERO-ALPHA-D-GALACTO-1-OCTOPYRANOSYL) PHOSPHONIC ACID
|
||
A SARS-CoV-2 neutralizing antibody
|
|||
A SARS-CoV-2 neutralizing antibody
|
|||
A SARS-CoV-2 neutralizing antibody
|
|||
A SARS-CoV-2 neutralizing antibody
|
|||
A PRO TO GLY MUTATION IN THE HINGE OF THE ARABINOSE-BINDING PROTEIN ENHANCES BINDING AND ALTERS SPECIFICITY: SUGAR-BINDING AND CRYSTALLOGRAPHIC STUDIES
|
|||
A PRO TO GLY MUTATION IN THE HINGE OF THE ARABINOSE-BINDING PROTEIN ENHANCES BINDING AND ALTERS SPECIFICITY: SUGAR-BINDING AND CRYSTALLOGRAPHIC STUDIES
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01